# Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

> **NCT06375811** · PHASE3 · RECRUITING · sponsor: **Yale University** · enrollment: 297 (estimated)

## Conditions studied

- Infertility
- Endometriosis

## Interventions

- **DRUG:** Elagolix 200 MG
- **OTHER:** Placebo or SOC IVF

## Key facts

- **NCT ID:** NCT06375811
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-16
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 297 (ESTIMATED)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375811, "Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06375811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*